24 May 2018 in Nature Microbiology
29 October 2013 in Molecular Systems Biology
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
4 October 2019 in Nature Communications
Antimicrobial peptides (AMPs) are promising antimicrobials, however, the potential of bacterial resistance is a major concern. Here we systematically study the evolution of resistance to 14 chemically diverse AMPs and 12 antibiotics in Escherichia coli. Our work indicates that evolution of resistance against certain AMPs, such as tachyplesin II and cecropin P1, is limited. Resistance level provided by point mutations and gene amplification is very low and antibiotic-resistant bacteria display no cross-resistance to these AMPs. Moreover, genomic fragments derived from a wide range of soil bacteria confer no detectable resistance against these AMPs when introduced into native host bacteria on plasmids. We have found that simple physicochemical features dictate bacterial propensity to evolve resistance against AMPs. Our work could serve as a promising source for the development of new AMP-based therapeutics less prone to resistance, a feature necessary to avoid any possible interference with our innate immune system.
1 July 2015 in Trends in Microbiology
8 July 2014 in Nature Communications
Understanding how evolution of antimicrobial resistance increases resistance to other drugs is a challenge of profound importance. By combining experimental evolution and genome sequencing of 63 laboratory-evolved lines, we charted a map of cross-resistance interactions between antibiotics in Escherichia coli, and explored the driving evolutionary principles. Here, we show that (1) convergent molecular evolution is prevalent across antibiotic treatments, (2) resistance conferring mutations simultaneously enhance sensitivity to many other drugs and (3) 27% of the accumulated mutations generate proteins with compromised activities, suggesting that antibiotic adaptation can partly be achieved without gain of novel function. By using knowledge on antibiotic properties, we examined the determinants of cross-resistance and identified chemogenomic profile similarity between antibiotics as the strongest predictor. In contrast, cross-resistance between two antibiotics is independent of whether they show synergistic effects in combination. These results have important implications on the development of novel antimicrobial strategies.
28 July 2014 in Proceedings of the National Academy of Sciences
Significance: Understanding how new metabolic pathways emerge is one of the key issues in evolutionary and systems biology. The prevailing paradigm is that evolution capitalizes on the weak side activities of preexisting enzymes (i.e. underground reactions). However, the extent to which underground reactions provide novelties in the context of the entire cellular system has remained unexplored. In this study, we present a comprehensive computational model of the underground metabolism of Escherichia coli . Together with a high-throughput experimental survey across hundreds of nutrient environments we predicted and confirmed new functional states of metabolism in which underground reactions allow growth when their activity is increased. Our approach has important implications for biotechnological and medical applications, such as understanding gain-of-function mutations in tumor development.